ID: MRFR/HC/5973-HCR | 90 Pages | Author: Rahul Gotadki | March 2024
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Macroeconomic Indicators
4.5 Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterβs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Opportunities
5.4 Pricing Analysis
Chapter 6. Global Albumin (as Excipient) Market, by Type
6.1 Introduction
6.2 Human Serum Albumin
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3 Bovine Serum Albumin
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.4 Recombinant Albumin
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 7. Global Albumin (as Excipient) Market, by Application
7.1 Introduction
7.2 Drug Formulation
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.3 Drug Delivery
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.4 Vaccines
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.5 Medical Device Coating
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.6 Culture Media & Stabilizers
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.7 Diagnostics
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.8 In Vitro Fertilization
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.9 Others
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 7. Global Albumin (as Excipient) Market, by End User
7.1 Introduction
7.2 Pharmaceutical & Biotechnology Industry
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.3 Academic and Research Institutes
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.5 Others
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 8. Global Albumin (as Excipient) Market, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 U.S.
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
Chapter 9. Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
Chapter 10. Company Profiles
10.1 Albumedix A/S (Novozyme A/S)
10.1.1 Company Overview
10.1.2 Product Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Biotest AG
10.2.1 Company Overview
10.2.2 Product Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 China Biologic Products Holdings, Inc.
10.3.1 Company Overview
10.3.2 Product Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 CSL Behring LLC
10.4.1 Company Overview
10.4.2 Product Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 Albumin Therapeutics, LLC
10.5.1 Company Overview
10.5.2 Product Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Baxalta Incorporated
10.6.1 Company Overview
10.6.2 Product Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Baxter International Inc.
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financial Overview
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Celgene
10.8.1 Overview
10.8.2 Product Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 Grifols International, S.A
10.9.1 Overview
10.9.2 Product Overview
10.9.3 Financials
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 Octapharma AG
10.10.1 Overview
10.10.2 Product Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.11 HiMedia Laboratories Pvt. Ltd.
10.11.1 Overview
10.11.2 Product Overview
10.11.3 Financials
10.11.4 Key Developments
10.11.5 SWOT Analysis
10.12 InVitria
10.12.1 Overview
10.12.2 Product Overview
10.12.3 Financials
10.12.4 Key Developments
10.12.5 SWOT Analysis
10.13 Medxbio Pte Ltd.
10.13.1 Overview
10.13.2 Product Overview
10.13.3 Financials
10.13.4 Key Developments
10.13.5 SWOT Analysis
10.14 Mitsubishi Tanabe Pharma Corporation
10.14.1 Overview
10.14.2 Product Overview
10.14.3 Financials
10.14.4 Key Developments
10.14.5 SWOT Analysis
10.15 RayBiotech, Inc.
10.15.1 Overview
10.15.2 Product Overview
10.15.3 Financials
10.15.4 Key Developments
10.15.5 SWOT Analysis
10.16 SeraCare Life Sciences
10.16.1 Overview
10.16.2 Product Overview
10.16.3 Financials
10.16.4 Key Developments
10.16.6 SWOT Analysis
10.17 Sigma-Aldrich Co. (Merck KGaA)
10.17.1 Overview
10.17.2 Product Overview
10.17.3 Financials
10.17.4 Key Developments
10.17.7 SWOT Analysis
10.18 Others
Chapter 11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEOβs Viewpoint
11.1.2 Unmet Needs of the Market
11.2 Key Companies to Watch
11.3 Predictionsfor the global albumin (as excipient) market
Chapter 12 Appendix
LIST OF TABLES
Table 1 Albumin (as Excipient) Market Synopsis, 2023-2030
Table 2 Albumin (as Excipient) Market Estimates and Forecast, 2023-2030 (USD Million)
Table 3 Global Albumin (as Excipient) Market, by Region, 2023-2030 (USD Million)
Table 4 Global Albumin (as Excipient) Market, by Type, 2023-2030 (USD Million)
Table 5 Global Albumin (as Excipient) Market, by Application, 2023-2030 (USD Million)
Table 6 Global Albumin (as Excipient) Market, End User, 2023-2030 (USD Million)
Table 7 North America: Albumin (as Excipient) Market, by Type, 2023-2030 (USD Million)
Table 8 North America: Albumin (as Excipient) Market, by Application, 2023-2030 (USD Million)
Table 9 North America: Albumin (as Excipient) Market, End User, 2023-2030 (USDMillion)
Table 10 US: Albumin (as Excipient) Market, by Type, 2023-2030 (USD Million)
Table 11 US: Albumin (as Excipient) Market, by Application, 2023-2030 (USD Million)
Table 12 US: Albumin (as Excipient) Market, End User, 2023-2030 (USD Million)
Table 13 Canada:Albumin (as Excipient) Market,by Type, 2023-2030 (USD Million)
Table 14 Canada: Albumin (as Excipient) Market, by Application, 2023-2030 (USD Million)
Table 15 Canada: Albumin (as Excipient) Market, End User, 2023-2030 (USDMillion)
Table 16 South America: Albumin (as Excipient) Market, by Type, 2023-2030 (USD Million)
Table 17 South America: Albumin (as Excipient) Market, by Application, 2023-2030 (USD Million)
Table 18 South America: Albumin (as Excipient) Market, End User, 2023-2030 (USDMillion)
Table 19 Europe: Albumin (as Excipient) Market, by Type, 2023-2030 (USD Million)
Table 20 Europe: Albumin (as Excipient) Market, by Application, 2023-2030 (USD Million)
Table 21 Europe: Albumin (as Excipient) Market, End User, 2023-2030 (USD Million)
Table 22 Western Europe: Albumin (as Excipient) Market, by Type, 2023-2030 (USDMillion)
Table 23 Western Europe: Albumin (as Excipient) Market, by Application, 2023-2030 (USD Million)
Table 24 Western Europe: Albumin (as Excipient) Market, by End User, 2023-2030(USD Million)
Table 25 Eastern Europe: Albumin (as Excipient) Market, by Type, 2023-2030 (USD Million)
Table 26 Eastern Europe: Albumin (as Excipient) Market, by Application, 2023-2030 (USD Million)
Table 27 Eastern Europe: Albumin (as Excipient) Market, End User, 2023-2030(USD Million)
Table 28 Asia-Pacific: Albumin (as Excipient) Market, by Type, 2023-2030 (USD Million)
Table 29 Asia-Pacific: Albumin (as Excipient) Market, by Application, 2023-2030 (USD Million)
Table 30 Asia-Pacific: Albumin (as Excipient) Market, End User, 2023-2030 (USD Million)
Table 31 Middle East & Africa: Albumin (as Excipient) Market, by Type, 2023-2030 (USD Million)
Table 32 Middle East & Africa: Albumin (as Excipient) Market, by Application, 2023-2030 (USD Million)
Table 33 Middle East & Africa: Albumin (as Excipient) Market, End User, 2023-2030(USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Albumin (as Excipient) Market
Figure 3 Market Dynamics for Global Albumin (as Excipient) Market
Figure 4 Albumin (as Excipient) Market Share, by Type, 2023
Figure 5 Albumin (as Excipient) Market Share, by Application, 2023
Figure 6 Albumin (as Excipient) Market Share, End User, 2023
Figure 7 Albumin (as Excipient) Market Share, by Region, 2023
Figure 8 North America: Albumin (as Excipient) Market Share, by Country, 2023
Figure 9 Europe: Albumin (as Excipient) Market Share, by Country, 2023
Figure 10 Asia-Pacific: Albumin (as Excipient) Market Share, by Country, 2023
Figure 11 Middle East & Africa: Albumin (as Excipient) Market Share, by Region, 2023
Figure 12 Albumin (as Excipient) Market: Company Share Analysis, 2023 (%)
Figure 13 Albumedix A/S (Novozyme A/S): Key Financials
Figure 14 Albumedix A/S (Novozyme A/S): Segmental Revenue
Figure 15 Albumedix A/S (Novozyme A/S): Geographical Revenue
Figure 16 Biotest AG: Key Financials
Figure 17 Biotest AG: Segmental Revenue
Figure 18 Biotest AG: Geographical Revenue
Figure 19 China Biologic Products Holdings, Inc.: Key Financials
Figure 20 China Biologic Products Holdings, Inc.: Segmental Revenue
Figure 21 China Biologic Products Holdings, Inc.: Geographical Revenue
Figure 22 CSL Behring LLC: Key Financials
Figure 23 CSL Behring LLC: Segmental Revenue
Figure 24 CSL Behring LLC: Geographical Revenue
Figure 25 Albumin Therapeutics, LLC: Key Financials
Figure 26 Albumin Therapeutics, LLC: Segmental Revenue
Figure 27 Albumin Therapeutics, LLC: Geographical Revenue
Figure 28 Baxalta Incorporated: Key Financials
Figure 29 Baxalta Incorporated: Segmental Revenue
Figure 30 Baxalta Incorporated: Geographical Revenue
Figure 31 Baxter International Inc.: Key Financials
Figure 32 Baxter International Inc.: Segmental Revenue
Figure 33 Baxter International Inc.: Geographical Revenue
Figure 34 Mitsubishi Tanabe Pharma Corporation: Key Financials
Figure 35 Mitsubishi Tanabe Pharma Corporation: Segmental Revenue
Figure 36 Mitsubishi Tanabe Pharma Corporation: Geographical Revenue
Figure 37 Celgene: Key Financials
Figure 38 Celgene: Segmental Revenue
Figure 39 Celgene: Geographical Revenue
Figure 40 Grifols International, S.A: Key Financials
Figure 41 Grifols International, S.A: Segmental Revenue
Figure 42 Grifols International, S.A: Geographical Revenue
Figure 43 Octapharma AG: Key Financials
Figure 44 Octapharma AG:Segmental Revenue
Figure 45 Octapharma AG: Geographical Revenue
Figure 46 HiMedia Laboratories Pvt. Ltd.: Key Financials
Figure 47 HiMedia Laboratories Pvt. Ltd.: Segmental Revenue
Figure 48 HiMedia Laboratories Pvt. Ltd.: Geographical Revenue
Figure 49 InVitria: Key Financials
Figure 50 InVitria: Segmental Revenue
Figure 51 InVitria: Geographical Revenue
Figure 52 Medxbio Pte Ltd.: Key Financials
Figure 53 Medxbio Pte Ltd.: Segmental Revenue
Figure 54 Medxbio Pte Ltd.: Geographical Revenue
Figure 55 SeraCare Life Sciences: Key Financials
Figure 56 SeraCare Life Sciences: Segmental Revenue
Figure 57 SeraCare Life Sciences: Geographical Revenue
Figure 58 Sigma-Aldrich Co. (Merck KGaA): Key Financials
Figure 59 Sigma-Aldrich Co. (Merck KGaA): Segmental Revenue
Figure 60 Sigma-Aldrich Co. (Merck KGaA): Geographical Revenue
Albumin (as Excipient) Market Segmentation
Albumin (as Excipient) Type Outlook (USD Billion, 2018-2030)
Human
Bovine
Recombinant Serum Albumin
Albumin (as Excipient) Application Outlook (USD Billion, 2018-2030)
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
Albumin (as Excipient) Regional Outlook (USD Billion, 2018-2030)
North America Outlook (USD Billion, 2018-2030)
North America Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
North America Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
US Outlook (USD Billion, 2018-2030)
US Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
US Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
CANADA Outlook (USD Billion, 2018-2030)
CANADA Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
CANADA Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
Europe Outlook (USD Billion, 2018-2030)
Europe Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
Europe Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
Germany Outlook (USD Billion, 2018-2030)
Germany Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
Germany Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
France Outlook (USD Billion, 2018-2030)
France Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
France Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
UK Outlook (USD Billion, 2018-2030)
UK Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
UK Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
ITALY Outlook (USD Billion, 2018-2030)
ITALY Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
ITALY Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
SPAIN Outlook (USD Billion, 2018-2030)
Spain Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
Spain Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
Rest Of Europe Outlook (USD Billion, 2018-2030)
Rest Of Europe Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
REST OF EUROPE Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
Asia-Pacific Outlook (USD Billion, 2018-2030)
Asia-Pacific Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
Asia-Pacific Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
China Outlook (USD Billion, 2018-2030)
China Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
China Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
Japan Outlook (USD Billion, 2018-2030)
Japan Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
Japan Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
India Outlook (USD Billion, 2018-2030)
India Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
India Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
Australia Outlook (USD Billion, 2018-2030)
Australia Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
Australia Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)
Rest of Asia-Pacific Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
Rest of Asia-Pacific Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
Rest of the World Outlook (USD Billion, 2018-2030)
Rest of the World Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
Rest of the World Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
Middle East Outlook (USD Billion, 2018-2030)
Middle East Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
Middle East Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
Africa Outlook (USD Billion, 2018-2030)
Africa Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
Africa Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics
Latin America Outlook (USD Billion, 2018-2030)
Latin America Albumin (as Excipient) by Type
Human
Bovine
Recombinant Serum Albumin
Latin America Albumin (as Excipient) by Application
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Diagnostics